IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Baker Bros. Advisors LP

Q1 2020 Holdings

Filed 2020-05-15 | 110 holdings | $4.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Reata Pharmaceuticals, Inc.(RETAEUR)CL A75615P103$8.1K55,9830.0%
Mirum Pharmaceuticals, Inc.(MIRM)COM604749101$8.2K583,3330.0%
Urovant Sciences Ltd.SHSG9381B108$9.2K1,000,0000.0%
Aimmune Therapeutics, Inc.(AIMT)COM00900T107$9.7K673,9080.0%
Protagonist Therapeutics, Inc.(PTGX)COM74366E102$11.9K1,679,1640.0%
UroGen Pharma Ltd.(URGN)COMM96088105$12.0K672,9120.0%
Xencor, Inc.(XNCR)COM98401F105$12.8K428,1200.0%
BioMarin Pharmaceutical Inc.NOTE 0.599% 8/1/202409061GAH4$15.6K$15,000,0000.0%
uniQure N.V.(QURE)SHSN90064101$16.9K357,0830.0%
Alkermes plc(ALKS)SHSG01767105$17.9K1,244,7440.0%
Frequency Therapeutics, Inc.COM35803L108$21.0K1,180,1620.0%
Assembly Biosciences, Inc.COM045396108$22.9K1,541,6180.0%
Apellis Pharmaceuticals, Inc.(APLS)COM03753U106$24.0K896,5510.0%
Merus N.V.COMN5749R100$24.7K2,037,4690.0%
GW Pharmaceuticals plcADS36197T103$32.5K370,8450.0%
Allakos Inc.(ALLKGUSD)COM01671P100$32.7K735,4690.0%
ChemoCentryx, Inc.(CCXIEUR)COM16383L106$34.5K859,0150.0%
Neoleukin Therapeutics, Inc.COM64049K104$38.7K3,397,7400.0%
Neurocrine Biosciences, Inc.NOTE 2.25% 5/15/202464125CAD1$39.3K$30,770,0000.0%
Krystal Biotech, Inc.(KRYS)COM501147102$40.9K946,4710.0%
Rhythm Pharmaceuticals, Inc.(RYTM)COM76243J105$41.2K2,708,2000.0%
Kiniksa Pharmaceuticals, Ltd.COM CL AG5269C101$43.3K2,799,5770.0%
Insmed Incorporated(INSM)COM PAR $.01457669307$48.5K3,025,3840.0%
DBV Technologies S.A.SPONSORED ADR23306J101$57.3K14,614,2640.0%
Atreca, Inc.(BCELUSD)CL A COM04965G109$58.5K3,532,7600.0%
Tricida, Inc.(1T7)COM89610F101$58.7K2,666,0150.0%
Zymeworks Inc.COM98985W102$60.6K1,708,4720.0%
Heron Therapeutics, Inc.(HRTX)COM427746102$70.7K6,018,1040.0%
MyoKardia, Inc.COM62857M105$83.2K1,774,2340.0%
Madrigal Pharmaceuticals, Inc.(MDGL)COM558868105$100.1K1,499,2120.0%
Ra Pharmaceuticals, Inc.COM74933V108$100.5K2,093,8390.0%
Exact Sciences Corporation(EXAS)COM30063P105$107.1K1,846,1390.0%
Neurocrine Biosciences, Inc.(NBIX)COM64125C109$107.3K1,240,2430.0%
Mirati Therapeutics, Inc.(MRTXEUR)COM60468T105$108.4K1,409,7840.0%
Principia Biopharma Inc.(PRNB)COM74257L108$116.1K1,955,4130.0%
Invitae Corporation(NVTA1EUR)COM46185L103$124.4K9,100,6150.0%
Amarin Corporation plcSPONSORED ADR023111206$138.0K34,496,6850.0%
CytomX Therapeutics, Inc.(CTMX)COM23284F105$153.0K20,0000.0%
IGM Biosciences, Inc.(1K0)COM449585108$176.5K3,144,0000.0%
Kodiak Sciences Inc.(KOD)COM50015M109$552.1K11,574,5380.0%
Alexion Pharmaceuticals, Inc.(ALXN)COM015351109$786.6K8,760,7940.0%
Autolus Therapeutics plc(AUTL)SPON ADS05280R100$939.0K156,7730.0%
Arcus Biosciences, Inc.(RCUS)COM03969F109$1.7M121,5340.0%
Incyte Corporation(INCY)COM45337C102$2.3M31,978,7850.1%
Crinetics Pharmaceuticals, Inc.(CRNX)COM22663K107$2.6M175,0000.1%
Catalyst Pharmaceuticals, Inc.(CPRX)COM14888U101$4.1M1,060,7140.1%
Cabaletta Bio, Inc.(CABA)COM12674W109$4.6M636,3630.1%
Seattle Genetics, Inc.COM812578102$5.8M50,060,2400.1%
Alector, Inc.(ALEC)COM014442107$6.8M280,0000.1%
Adaptimmune Therapeutics plc(ADAPY)SPONSORED ADR00653A107$10.0M3,690,3070.2%
PreviousPage 2 of 3Next